XORTX Therapeutics Inc. stocks have been trading up by 16.7 percent following highly positive biotech pipeline advancement ...

Teva stock is a "Hold" as its "Pivot to Growth" strategy shows early promise but requires further execution. Click for more ...

WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) ...

Identifying what leads to short-term salesWhen they hear about growth strategies or new businesses, many advertising agency ...

According to MarketsandMarkets™, the Pharmaceutical Excipients Market is projected to reach USD 15.99 billion by 2031 from USD 11.95 billion ...

WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) formulation of olanzapine for the ...

The company, which is celebrating 80 years in business, has created some of beauty's most recognizable heroes - and plans to ...

Takara Standard announced on the 9th that it will make software developer Sigma Consulting a subsidiary. This marks the ...

Spread the loveThe pharmaceutical industry’s pursuit of effective weight-loss solutions has been nothing short of a modern ...

For manufacturers and brand owners, identifying that gap before committing to another round of changes could save time, money ...

NCLT Chandigarh dispenses with shareholder and creditor meetings in Asics India–Onitsuka Tiger demerger first-motion ...

American partner Teva Pharmaceuticals has received approval from the U.S. Food and Drug Administration for a monthly ...